Market News & Trends
Eli Lilly Breaks Ground on $6.5B Houston API Facility to Scale Oral GLP-1 and Genetic Medicines
Eli Lilly and Company has officially broken ground on a massive $6.5 billion active pharmaceutical ingredient (API) manufacturing campus in Houston, Texas. The facility marks…
Magnitude Biosciences Secures $1.72M to Scale C. elegans High-Throughput In Vivo Screening Platform
Contract research organization and Durham University spinout Magnitude Biosciences has closed a $1.72 million investment round to accelerate the commercial scale-up of its flagship in…
SCHOTT Pharma and Nemera Co-Develop Integrated 5.5 mL Syringe and Safety Platform to Advance At-Home Biologic Delivery
As biopharma accelerates the transition from hospital-based intravenous (IV) infusions to at-home subcutaneous administration, containment and delivery specialists SCHOTT Pharma and Nemera have partnered to…
Bespak, Upperton Team Up on Integrated Nasal Drug Product Development
Bespak and Upperton are combining their respective drug-development capabilities in a new collaboration aimed at helping pharmaceutical companies move nasal drug products from early formulation…
Kincell Bio, Cellipont Bioservices Complete Merger to Create Kincellis Advanced Therapies
Kincell Bio and Cellipont Bioservices have completed their previously announced merger, bringing the two advanced-therapy organizations together under a new company, Kincellis Advanced Therapies. The…
AI Algorithm Guides Modified-Release Tablet Design in Ongoing Clinical Study
An artificial intelligence algorithm has selected modified-release tablet formulations and dose levels during an ongoing clinical study, according to interim findings reported by Quotient Sciences.…
Upperton Secures MHRA Approval for New Sterile Manufacturing Facility
CDMO Upperton Pharma Solutions has received approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to begin GMP manufacture of sterile investigational medicinal…
New Hovione Facility Expands U.S. Capacity for Poorly Soluble Drug Development
CDMO Hovione has opened a new 31,000-square-foot facility at its East Windsor, New Jersey campus, doubling its US spray drying capacity as the company expands…
RSSL Launches Pharmaceutical Consultancy Service to Support Complex Drug Development and Manufacturing Challenges
Reading Scientific Services Ltd (RSSL) has launched a dedicated pharmaceutical consultancy offering aimed at helping pharmaceutical, biopharmaceutical and advanced therapy companies address increasingly complex challenges…
Zeteo Biomedical Takes Active Powder Delivery Platform Into Pulmonary Market
Zeteo Biomedical is moving beyond nasal drug delivery and into pulmonary applications with AriesMR, a reloadable dry powder inhaler intended to actively disperse pharmaceutical powders…
AI Failures Cost Life Sciences Organizations Millions as Process Gaps Persist
Artificial Intelligence adoption is accelerating across the healthcare and life sciences sectors, but poorly designed processes are emerging as a major obstacle to successful implementation,…
Ecolab Adds Resin Manufacturing Capacity With New Quzhou Facility
Ecolab is expanding its manufacturing and R&D footprint in China with the opening of a new resin production facility in Quzhou, a move aimed at…
Novo Nordisk Launches ‘Novo’ Rebrand to Sharpen Global Identity
Novo Nordisk is repositioning its corporate identity as it prepares for what the company describes as its next chapter, introducing a new brand platform, adopting…
BioLife Wins US Patent for Effervescent Oral Peptide Delivery Platform
BioLife has received a US patent for an effervescent tablet technology intended to enable oral delivery of peptide therapeutics, including GLP-1 receptor agonists used in…
AbbVie Strengthens Dermatology and Respiratory Pipeline With Apogee Acquisition
AbbVie has completed its acquisition of Apogee Therapeutics, adding a portfolio of long-acting antibody programs to its immunology and inflammation pipeline as the pharmaceutical company…
Lonza to Add Commercial Spray-Drying Capacity at Oregon Manufacturing Site
Constructed is expected to be completed on two new PSD-4 units that will expand Lonza’s US-based capacity for spray-dried dispersions, as drug developers face increasing…
Sandoz Plans Biosimilar Drug Substance Facility in Slovenia
Sandoz is planning a roughly $300 million investment in a new biosimilar drug substance manufacturing facility in Ljubljana, Slovenia, as the company moves to expand…
Xeris Taps medmix Pen Platform for Once-Weekly Levothyroxine Program
Xeris Pharmaceuticals has selected medmix’s Drug Delivery business, formerly known as Haselmeier, to provide the injection device for XP-8121, an investigational once-weekly subcutaneous formulation of…
Novartis Reassesses Del-desiran Program After Phase III DM1 Study Misses Primary Endpoint
Novartis is reassessing the development strategy for delpacibart etedesiran (del-desiran) after the investigational therapy failed to achieve the primary endpoint in a pivotal Phase III…
Allogenetics Secures $4.4M to Move Transplant Gene Therapy Toward Clinical Trials
German biotechnology company Allogenetics has raised approximately $4.4 million in a Pre-Series A financing round to advance an ex vivo gene therapy designed to reduce…
